|
RAP2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
2.35829999999382E-05 |
| Normal-vs-Stage3 |
4.37169999978337E-07 |
| Normal-vs-Stage4 |
2.483600E-02 |
| Stage1-vs-Stage2 |
1.615630E-02 |
| Stage1-vs-Stage3 |
1.119990E-01 |
| Stage1-vs-Stage4 |
8.291200E-01 |
| Stage2-vs-Stage3 |
4.189200E-01 |
| Stage2-vs-Stage4 |
1.389960E-01 |
| Stage3-vs-Stage4 |
2.783800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.79170000344808E-08 |
| Normal-vs-Asian |
3.219900E-02 |
| Caucasian-vs-AfricanAmerican |
8.193600E-01 |
| Caucasian-vs-Asian |
8.663400E-01 |
| AfricanAmerican-vs-Asian |
8.481000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
4.7424952853703E-11 |
| Male-vs-Female |
4.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.26179999782039E-08 |
| Normal-vs-Extreme_Weight |
1.68065561467756E-12 |
| Normal-vs-Obese |
2.73320255317344E-11 |
| Normal-vs-Extreme_Obese |
4.092300E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.592400E-01 |
| Normal_Weight-vs-Obese |
8.110600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.545000E-01 |
| Extreme_Weight-vs-Obese |
7.342400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.383600E-01 |
| Obese-vs-Extreme_Obese |
7.127800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.849000E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
4.318400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.352040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.837380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.940580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.987200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.676600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.996800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
2.33170038832498E-10 |
| Normal-VS-KIRP CIMP |
5.964600E-04 |
| Normal-VS-Unclassified PRCC |
1.10010001108662E-09 |
| Type1 PRCC-VS-Type2 PRCC |
8.791800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.9229000000034E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.330400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.898900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.443800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.703890E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92149995914548E-09 |
| Normal-vs-N1 |
1.59188999999671E-05 |
| Normal-vs-N2 |
2.621200E-01 |
| N0-vs-N1 |
4.752400E-01 |
| N0-vs-N2 |
9.997800E-01 |
| N1-vs-N2 |
7.663800E-01 |
|
|
